Company / Depreciation & Amortization
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$13.0M
FY2025
5-year range
$7.2M / $13.8M
FY2021-FY2025
Trend
-5.7%
vs FY2024
Sector context
#112 of 141
Health Care
What the data says
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s depreciation & amortization of $13M is lower than 79% of companies in the Health Care sector (FY2025). Depreciation & Amortization has fluctuated over the past 10 years, ranging from $4M in FY2016 to $14M in FY2024.
Based on SEC 10-K filings.
$13M in FY2025 with a 5-year CAGR of +15.1%.
Increased from $11M to $13M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +11.1%
- 5-Year CAGR
- +15.1%
- 10-Year CAGR
- -
Sector benchmark
-96.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +15.1%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 5.7% year-over-year.
- Ranks #112 out of 141 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.0M | -5.7% |
| FY2024 | $13.8M | +20.2% |
| FY2023 | $11.5M | +20.9% |
| FY2022 | $9.5M | +31.7% |
| FY2021 | $7.2M | +12.0% |
| FY2020 | $6.4M | -11.5% |
| FY2019 | $7.3M | +0.7% |
| FY2018 | $7.2M | -14.5% |
| FY2017 | $8.4M | +117.9% |
| FY2016 | $3.9M | -31.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026